339 related articles for article (PubMed ID: 35167654)
1. Guiding the global evolution of cytogenetic testing for hematologic malignancies.
Akkari YMN; Baughn LB; Dubuc AM; Smith AC; Mallo M; Dal Cin P; Diez Campelo M; Gallego MS; Granada Font I; Haase DT; Schlegelberger B; Slavutsky I; Mecucci C; Levine RL; Hasserjian RP; Solé F; Levy B; Xu X
Blood; 2022 Apr; 139(15):2273-2284. PubMed ID: 35167654
[TBL] [Abstract][Full Text] [Related]
2. Whole genome scanning as a cytogenetic tool in hematologic malignancies.
Maciejewski JP; Mufti GJ
Blood; 2008 Aug; 112(4):965-74. PubMed ID: 18505780
[TBL] [Abstract][Full Text] [Related]
3. Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and Genomics Cytogenetics Committee.
Larson DP; Akkari YM; Van Dyke DL; Raca G; Gardner JA; Rehder CW; Kaiser-Rogers KA; Eagle P; Yuhas JA; Gu J; Toydemir RM; Kearney H; Conlin LK; Tang G; Dolan MM; Ketterling RP; Peterson JF
Arch Pathol Lab Med; 2021 Feb; 145(2):176-190. PubMed ID: 32886736
[TBL] [Abstract][Full Text] [Related]
4. Implication of cytogenetic and molecular cytogenetic analysis in diagnosis of hematological malignancies in the era of the new sequencing techniques.
Zemanová Z; Michalová K; Březinová J
Cas Lek Cesk; 2019; 158(1):22-27. PubMed ID: 31046388
[TBL] [Abstract][Full Text] [Related]
5. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics in the genomic era.
Granada I; Palomo L; Ruiz-Xivillé N; Mallo M; Solé F
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101196. PubMed ID: 33038985
[TBL] [Abstract][Full Text] [Related]
7. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
[TBL] [Abstract][Full Text] [Related]
8. Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities.
Mikhail FM; Heerema NA; Rao KW; Burnside RD; Cherry AM; Cooley LD
Genet Med; 2016 Jun; 18(6):635-42. PubMed ID: 27124785
[TBL] [Abstract][Full Text] [Related]
9. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
[TBL] [Abstract][Full Text] [Related]
10. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Tansatit M
Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
[TBL] [Abstract][Full Text] [Related]
11. Molecular Diagnosis of Hematopoietic Neoplasms: 2018 Update.
Ramchandren R; Jazaerly T; Bluth MH; Gabali AM
Clin Lab Med; 2018 Jun; 38(2):293-310. PubMed ID: 29776632
[TBL] [Abstract][Full Text] [Related]
12. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gachard N; Lafage-Pochitaloff M; Quessada J; Auger N; Collonge-Rame MA
Curr Res Transl Med; 2023; 71(4):103416. PubMed ID: 37865978
[TBL] [Abstract][Full Text] [Related]
14. [Novel diagnostic procedures for hematologic malignancies on the basis of genomic alterations].
Taniwaki M
Rinsho Ketsueki; 2001 May; 42(5):352-5. PubMed ID: 11452449
[No Abstract] [Full Text] [Related]
15. The use of new technologies in the detection of balanced translocations in hematologic disorders.
Shaffer LG; Schultz RA; Ballif BC
Curr Opin Genet Dev; 2012 Jun; 22(3):264-71. PubMed ID: 22336526
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetics in the management of hematologic malignancies: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Nguyen-Khac F; Daudignon A; Eclache V; Lafage-Pochitaloff M; Lefebvre C; Luquet I; Penther D
Ann Biol Clin (Paris); 2016 Oct; 74(5):509-510. PubMed ID: 27465598
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics in Oral Cancer: A Comprehensive Update.
Sv S; Augustine D; Haragannavar VC; Khudhayr EA; Matari MH; Elagi WA; Gujjar N; Patil S
J Contemp Dent Pract; 2022 Jan; 23(1):123-131. PubMed ID: 35656669
[TBL] [Abstract][Full Text] [Related]
18. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
[TBL] [Abstract][Full Text] [Related]
19. Location and function of critical genes in leukemogenesis inferred from cytogenetic abnormalities in hematologic malignancies.
Bernard OA; Berger R
Semin Hematol; 2000 Oct; 37(4):412-9. PubMed ID: 11071362
[TBL] [Abstract][Full Text] [Related]
20. t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies.
Bernués M; González T; Corchete LA; Santos S; Durán MA; López-Andrade B; Riso LL; Martínez-Serra J; Ramos R; Iglesias J; Royo I; Rosell J
Cancer Genet; 2022 Jun; 264-265():60-65. PubMed ID: 35397254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
